As part of the adaptation of maternal glucose regulation during pregnancy to ensure glucose provision to the fetus, maternal insulin concentrations become elevated. However, increased central actions of insulin, such as suppression of appetite, would be maladaptive during pregnancy. We hypothesized that central nervous system targets of insulin become less responsive during pregnancy to prevent overstimulation by the increased circulating insulin concentrations. To test this hypothesis, we have measured insulin-induced phosphorylation of Akt (pAkt) in specific hypothalamic nuclei as an index of hypothalamic insulin responsiveness. Despite higher endogenous insulin concentrations following feeding, arcuate nucleus pAkt levels were significantly lower in the pregnant group compared with the nonpregnant group. In response to an intracerebroventricular injection of insulin, insulin-induced pAkt was significantly reduced in the arcuate nucleus and ventromedial nucleus of pregnant rats compared with nonpregnant rats. Similar levels of insulin receptor b and PTEN, a negative regulator of the phosphoinositide 3-kinase/Akt pathway, were detected in hypothalamic areas of nonpregnant and pregnant rats. In the ventromedial nucleus, however, levels of phosphorylated PTEN were significantly lower in pregnancy, suggesting that reduced inactivation of PTEN may contribute to the attenuated insulin signaling in this area during pregnancy. In conclusion, these results demonstrate region-specific changes in responsiveness to insulin in the hypothalamus during pregnancy that may represent an adaptive response to minimize the impact of elevated circulating insulin on the maternal brain. (Endocrinology 158: 4257-4269, 2017) D uring pregnancy, the mother undergoes major adaptations in her glucose homeostasis to constantly supply the growing fetus with glucose. Normally, insulin leads to an increase in glucose uptake in peripheral tissue, particularly muscle and fat. As pregnancy advances, however, these maternal tissues become relatively insulin resistant to direct glucose toward the fetus (1, 2). Although these maternal tissues can use other fuels, glucose is still required, and to counterbalance the fetal glucose diversion, maternal insulin production is increased during pregnancy to ensure an adequate uptake of glucose despite the loss of insulin sensitivity. To meet this demand for insulin, the threshold for glucose-stimulated insulin secretion from the pancreatic b cell is lowered, such that, at normal blood glucose levels, insulin release is significantly increased during pregnancy compared with the nonpregnant state (3). In rodents, there is a placental lactogen-induced increase in size and number of b cells in the pancreas to support the increase in demand for insulin (3). As a result of these pregnancy-induced changes in glucose homeostasis, circulating insulin concentrations increase during pregnancy (3-7).
D
uring pregnancy, the mother undergoes major adaptations in her glucose homeostasis to constantly supply the growing fetus with glucose. Normally, insulin leads to an increase in glucose uptake in peripheral tissue, particularly muscle and fat. As pregnancy advances, however, these maternal tissues become relatively insulin resistant to direct glucose toward the fetus (1, 2) . Although these maternal tissues can use other fuels, glucose is still required, and to counterbalance the fetal glucose diversion, maternal insulin production is increased during pregnancy to ensure an adequate uptake of glucose despite the loss of insulin sensitivity. To meet this demand for insulin, the threshold for glucose-stimulated insulin secretion from the pancreatic b cell is lowered, such that, at normal blood glucose levels, insulin release is significantly increased during pregnancy compared with the nonpregnant state (3). In rodents, there is a placental lactogen-induced increase in size and number of b cells in the pancreas to support the increase in demand for insulin (3) . As a result of these pregnancy-induced changes in glucose homeostasis, circulating insulin concentrations increase during pregnancy (3) (4) (5) (6) (7) .
In addition to the classic insulin-sensitive tissues, including the liver, muscle, and fat, insulin receptors are found on a wide range of other tissues within the body, including the hypothalamus (8, 9) . It is important to recognize that insulin signaling does not exclusively regulate Glut-4-mediated transport of glucose into cells, but also activates a number of intracellular signaling pathways. Hypothalamic neurons do not need insulin for glucose uptake, but widespread expression of insulin receptors suggests many neural regions respond to insulin. Neuron-specific deletion of insulin receptors has demonstrated that insulin signaling within the central nervous system is involved in the regulation of energy homeostasis, including maintaining body weight and whole-body insulin sensitivity (10) . Central insulin administration can inhibit food intake (11) (12) (13) , whereas intrahypothalamic infusion of insulin antibodies (14, 15) or insulin receptor antisense oligonucleotides (16) increases food intake and body weight. Central insulin action is also involved in the regulation of peripheral glucose homeostasis (17) , playing an important role in the regulation of hepatic glucose production, a vital process in the maintenance of blood glucose levels (18) (19) (20) (21) . Central infusions of insulin can lead to the suppression of hepatic glucose production (19) , supporting a proposed role of central insulin in an extrahepatic, or indirect, pathway that can regulate hepatic glucose production.
Given the elevated circulating insulin concentrations during pregnancy, it would be expected that there would be increased central insulin signaling during pregnancy. Established central functions of insulin, however, such as suppression of food intake and reduced hepatic production of glucose, would be maladaptive to optimal pregnancy outcome. Indeed, food intake is increased during pregnancy (22) (23) (24) , and hepatic glucose output is either unaffected (25) or increased (1) during pregnancy, suggesting that hypothalamic responses to insulin may be suppressed during pregnancy. Moreover, pregnancy is associated with decreased sensitivity to leptin in the hypothalamus, particularly the arcuate nucleus (26) and the ventromedial nucleus (VMH) (22, 27, 28) , and complete insulin signaling in the hypothalamus, at least within the arcuate nucleus, requires normal leptin signaling (29) . Our hypothesis is that pregnancy is associated with decreased insulin sensitivity in the hypothalamus and that this is an adaptive response to minimize the impact of elevated circulating insulin on the brain. Therefore, the aim of this study was to examine insulin sensitivity in the hypothalamus during pregnancy in the rat in response to an intracerebroventricular (ICV) injection of insulin or in response to feeding, using phosphorylation of Akt (pAkt) as a marker of insulin action. Day 14 of pregnancy was investigated because previous work has shown increased insulin concentrations at this time (6) , along with central leptin insensitivity, which may itself affect insulin-induced pAkt (29) . Moreover, although plasma insulin concentrations on day 14 of pregnancy are higher than in nonpregnant rats, several insulin-responsive genes in the VMH are not different, suggesting reduced insulin action in the this area (6) . Because it was of particular importance for our main aim to determine if glucosestimulated insulin secretion was increased at this time, we also examined glucose homeostasis on day 14 of pregnancy to characterize the changes exhibited by this time point during pregnancy. Further understanding of hormonal impact on central insulin responses may be important for a full understanding of the adaptive changes in glucose homeostasis during pregnancy and the possible mechanisms underlying development of gestational diabetes mellitus.
Methods

Animals
Ten-week-old female Sprague Dawley rats were obtained from our colony at the University of Otago and housed under a 14:10 light/dark cycle (lights on at 5:00 AM). Temperature was maintained at 22 6 1°C. All animals had free access to food and water, except during fasting when only water was available. All experimental protocols were approved by the University of Otago Animal Ethics Committee. The estrous cycle was monitored by daily cytological examination of vaginal smears. To generate timed pregnancies, proestrous females were housed overnight with a male rat and impregnation was confirmed by the presence of sperm in the vaginal smear the following morning (day 0 of pregnancy).
Endogenous insulin concentrations and hypothalamic pAkt in pregnant rats
On day 14 of pregnancy, and on metestrus for the nonpregnant rats, food was removed from the cages 6 hours before the start of the dark phase. At the onset of the dark phase, food was returned to cages and animals were left for 45 minutes, at which point they were decapitated and trunk blood was collected. Brains were immediately removed, frozen, and then stored at 280°C until further processing for western blot analysis. Blood glucose measurements were immediately measured using a glucometer (Accu-Chek Performa; Roche, Mannheim, Germany) at the time of blood sample collection. After collection, blood was centrifuged and plasma was collected and stored at 220°C. Insulin concentrations were measured in plasma samples using a rat insulin radioimmunoassay kit (Millipore, Billerica, MA) following the manufacturer's instructions.
Glucose-stimulated insulin secretion and glucose tolerance in pregnant rats
Groups of nonpregnant and pregnant rats underwent surgery for the placement of an indwelling atrial cannula for serial blood sample collection approximately 2 days before the day of testing. Briefly, animals were anesthetized with isoflurane gas and an incision was made in the skin to expose the right jugular vein. A cannula made of SILASTIC brand silicon tubing (Dow Corning Corp., Midland, MI; internal diameter 0.025 inches, external diameter 0.047 inches) and filled with heparinized saline was inserted into the right atrium via the right jugular vein. The end of the cannula was exteriorized through the skin between the scapulae so that it could be readily accessed for blood sampling. On day 13 of pregnancy or metestrus, food was removed from cages just before the start of the dark phase and animals were fasted overnight. Approximately 16 hours later, a blood sample (400 mL) was collected via the indwelling cannula and fasting blood glucose levels were immediately measured, as described previously. Thirty minutes later, a second blood sample was taken and rats immediately received an intraperitoneal (IP) injection of 2 g/kg glucose dissolved in saline. Blood glucose concentrations were then measured every 3 minutes for 30 minutes, then again at 60 and 120 minutes following glucose injection. Larger blood samples (400 mL) were collected 10, 30, 60, and 120 minutes after glucose injection and processed for plasma insulin concentrations, as described previously.
Intravenous insulin challenge during pregnancy
Groups of nonpregnant and pregnant rats underwent surgery for the placement of an indwelling atrial cannula as described previously. On the day of testing, either diestrous for the nonpregnant group or day 14 of pregnancy, food was removed at 9:00 AM, approximately 2 hours before insulin administration at 11:00 AM. Blood glucose levels were measured, as described previously, both 30 minutes and immediately before rats received an intravenous (IV) injection of insulin (75 U/kg), then again 15, 30, 60, 90, and 120 minutes after insulin administration.
Pyruvate challenge during pregnancy
Groups of nonpregnant and pregnant rats underwent surgery for the placement of an indwelling atrial cannula as described previously. Rats were fasted overnight and, the following morning, blood glucose levels were measured both 30 minutes and immediately before they were given an IP injection of pyruvate (2 g/kg in saline) or saline, then again 30, 60, 90, 120, 180, and 240 minutes after pyruvate administration. Nonpregnant rats were in the diestrous phase of the estrous cycle and pregnant rats were tested on day 14 of pregnancy.
Hypothalamic response to exogenous central insulin during pregnancy
ICV cannulae (Plastics One, Roanoke, VA) were stereotaxically placed into the left lateral ventricle of nonpregnant (random day of estrous cycle) and pregnant rats (days 5-7 of pregnancy), as previously described (22) . Guide cannulae were implanted such that the tips were positioned 1 mm above the left lateral ventricle (1.3 mm lateral to Bregma, 3 mm below the top of the skull). Injection cannulae were prepared such that they projected 1 mm beyond the end of the guide cannulae, into the lumen of the lateral ventricle. After surgery, rats were housed individually and weight gain was monitored daily for approximately a week of recovery before they were used in experiments. During this recovery period, patency of the cannula was assessed by ICV injection of 50 ng angiotensin (Bachem, Torrance, CA), followed by monitoring of water intake. Only rats that showed an immediate increase in drinking behavior after ICV angiotensin, consuming .5 mL in the 30 minutes after injection, were included in the study.
On day 14 of pregnancy, and on diestrous for the nonpregnant female rats, food was removed from the cages at 9:00 AM (4 hours after the start of the light phase). Approximately 2 hours later, rats received an ICV injection of either vehicle or insulin (10 mU; catalog no. I5523; Sigma-Aldrich Missouri); rats were then euthanized by decapitation 30 minutes later and blood glucose level was immediately measured in trunk blood using a glucometer (Accu-Chek Performa). This time point was selected because previous studies indicated that centrally injected insulin does not increase hypothalamic pAkt until 10 to 15 minutes after injection, and remains at a similar high level until at least 120 minutes after injection (30, 31) . Similar to others (30) , our data in nonpregnant female rats demonstrated that plasma insulin concentrations were not significantly altered by the ICV insulin injection (vehicletreated 1.9 ng/mL 6 0.3 ng/mL vs insulin-treated 2.5 ng/ mL 6 0.4 ng/mL, P = 0.23, n = 6-7 per group). Brains were rapidly removed, frozen, and then stored at 280°C until further processing for western blot analysis. An additional group of rats, similarly injected with either vehicle or insulin (4-5 per group), was anesthetized with sodium pentobarbitone and transcardially perfused with heparinized saline, followed by 4% paraformaldehyde in 0.1M phosphatebuffered saline. Brains were removed and postfixed in the same fixative overnight at room temperature. Brains were then immersed in 30% sucrose in 0.1M phosphate-buffered saline until they sunk, then rapidly frozen and stored until further processing for immunohistochemistry.
Western blot analysis
Hypothalamic nuclei were microdissected from brains using a micropunch technique as previously described (22, 32) . The protein concentration in each sample was determined by a modification of the Lowry method using a protein assay kit (Bio-Rad Laboratories Inc., Hercules, CA). Samples containing 10 mg of protein were heated at 96°C for 4 minutes after the addition of loading buffer containing 2-b mercaptoethanol, and were then separated on a 7.5% sodium dodecyl sulfatepolyacrylamide gel electrophoresis gel and electrotransferred to nitrocellulose membrane. Membranes were incubated in LI-COR blocking buffer (LI-COR Biosciences, Lincoln, NE) diluted 1:1 in Tris-buffered saline (TBS) for 1 hour at room temperature, and then incubated overnight at 4°C with primary antibody in TBS/0.1% Tween 20/0.1% bovine serum albumin. Unless otherwise specified, all primary antibodies used were purchased from Cell Signaling Technology, Inc. (Beverly, MA). Primary antibodies used were mouse anti-Akt (1:1000; catalog no. 2920), rabbit anti-phospho-Akt (ser473) (1:1000; catalog no. 4060), mouse anti-ERK(1/2) (1:1000; catalog no. 9107), rabbit anti-phospho (Thr202/Tyr204)-ERK(1/2) (1:1000; catalog no. 4370), rabbit anti-phospho-PTEN (1:1000; catalog no. 9554), mouse anti-PTEN (1:1000; catalog no. 9556), mouse anti-insulin receptor b (1:1000; catalog no. 3020), mouse anti-b actin (1:3000; catalog no. ab8226; Abcam, Cambridge, UK), and rabbit anti-b tubulin (1:3000; catalog no. 2146). Membranes were then incubated with anti-mouse and anti-rabbit IgG-IRDye-conjugated secondary antibodies (1:10,000) in TBS (catalog nos. 926-32210 and 926-32221; Millennium Science; Mulgrave, VIC, Australia) for 1 hour at room temperature. Fluorescence was visualized using the LI-COR Odyssey IR Fluorescence Imaging system and images were quantified using the LI-COR Odyssey software. The nonpregnant group (vehicle-treated when more than one nonpregnant group was used) was normalized to a value of 1 and all data are expressed relative to this group. Loading control (either b-tubulin or b-actin) values were compared with ensure equivalent protein loading between samples. All primary antibodies detected a single band of appropriate size, and no band was observed when either secondary or primary antibody was omitted.
pAkt immunohistochemistry
Coronal sections (35 mm) were sliced throughout the arcuate nucleus and collected in three series containing sections 105 mm apart. One series was processed for immunohistochemistry using a phospho-Akt specific antibody [rabbit antiphospho-Akt (ser473); 1:1000; catalog no. 4060]. Sections were washed five times with TBS/0.3% triton for 10 minutes per wash, incubated for 10 minutes in TBS/0.3% H 2 O 2 /10% methanol, and washed a further three times. Sections were incubated in blocking solution (TBS/0.3% triton/5% normal goat serum/) for 1 hour. Following this, sections were incubated for 24 hours at 4°C in blocking solution containing the rabbit anti-pAkt antibody. Following a series of three washes, sections were then incubated for 1 hour at room temperature with a biotinylated goat anti-rabbit antibody (dilution 1:2000), then for another hour with an avidinbiotin-peroxidase complex (Vectastain Elite ABC kit; Vector Laboratories, Burlingame, CA); finally, the peroxidase signal was visualized using 3,3 0 -diaminobenzideine (DAB kit; Vector Laboratories). Sections were viewed and photographed on an Olympus AX70 research microscope (Olympus, Tokyo, Japan). The number of cells positive for pAkt immunoreactivity was quantified in the arcuate nucleus (approximately 21.90 to 23.20 mm, relative to Bregma) (33) and at least three sections were analyzed per animal. For each rat, the average number of positive cells per section was calculated and used for statistical comparisons between treatment groups.
Statistical analysis
Data are mean 6 standard error of the mean, and all statistical analysis was undertaken using GraphPad Prism 6 (GraphPad); P , 0.05 was considered to be statistically significant. Food intake, glucose concentrations, and plasma insulin concentrations at a single time point, glucose tolerance test (GTT) area under the curve (AUC), insulin concentrations during GTT AUC, percentage change of glucose after insulin administration and pyruvate challenge AUC were analyzed using Student t test. Glucose levels over time in the GTT, insulin challenge, and pyruvate challenge, along with insulin concentrations in the GTT were analyzed by repeated measures analysis of variance (ANOVA) followed by Sidak or Tukey multiple comparison tests where appropriate. Western blot data comparisons between nonpregnant and pregnant groups were analyzed using Student t test, whereas comparisons between different treatments (vehicle or insulin) in nonpregnant and pregnant groups were analyzed using two-way ANOVA. Immunohistochemistry cell counts were analyzed by two-way ANOVA.
Results
Endogenous insulin concentrations and glucose homeostasis during pregnancy
To examine endogenous plasma insulin concentrations in pregnant and nonpregnant rats in a period of dynamic feeding, insulin concentrations were measured 45 minutes into the dark phase. During this time, pregnant and nonpregnant rats consumed similar amounts of food (2.41 6 0.27 and 2.06 6 0.63 g, respectively). Blood glucose concentrations were significantly lower (P = 0.005) and plasma insulin concentrations significantly higher (P = 0.033) in pregnant rats compared with nonpregnant rats (Fig. 1) .
When rats were not fasted, as in the insulin challenge, pregnant rats had significantly lower basal blood glucose concentrations compared with nonpregnant groups (80.6 6 3.9 vs 127.4 6 7.9 mg/dL P = 0.002). Similarly, when fasted, as in the GTT and pyruvate challenge experiments, pregnant rats also had significantly lower basal blood glucose concentrations compared with nonpregnant groups (results pooled from both studies: 77.1 6 3.2 vs 89.6 6 2.7 mg/dL, P = 0.006).
To examine the adaptive changes in glucose regulation during pregnancy, different groups of day 14 pregnant and nonpregnant rats underwent a GTT, an IV insulin challenge, or a pyruvate challenge. The blood glucose response to the GTT was significantly different in day 14 pregnant rats compared with nonpregnant rats [interaction of time and physiological state, F(13, 182) = 2.224, P = 0.0101]. More specifically, glucose levels were significantly less in pregnant rats compared with nonpregnant rats between 16 and 30 minutes after glucose injection ( Fig. 2A; P , 0.05) . Similarly, AUC during the GTT indicated day 14 pregnant rats had increased glucose tolerance compared with nonpregnant rats ( Fig. 2A ; P = 0.002). Insulin concentrations were increased in all physiological states in response to glucose administration [main effect of time, F(4, 48) = 22.82, P , 0.0001], and there was a trend for insulin concentrations to be higher in the pregnant rats compared with nonpregnant rats, but this was not quite significant [main effect of physiological state F(1,12) = 4.661, P = 0.051] (Fig. 2B) . When AUC was calculated on day 14 of pregnancy, the insulin response to glucose administration was significantly greater than that of the nonpregnant group ( Fig. 2B ; P = 0.008). The blood glucose response to the insulin challenge was significantly different in day 14 pregnant rats compared with nonpregnant rats [interaction of time and physiological state, F(6,54) = 4.883, P = 0.0005] (Fig. 2C) . In response to IV insulin, both nonpregnant and day 14 pregnant rats had a decrease in blood glucose levels 15 minutes later that then returned to basal levels by 60 minutes in both groups. Although both nonpregnant Figure 2 . (A) Glucose tolerance test in fasted nonpregnant (n = 7) and day 14 pregnant (n = 9) rats. Directly after blood glucose measurement at time 0, rats received an IP injection of glucose (2 g/kg dissolved in saline) and blood glucose levels were measured every 3 minutes for 30 minutes, then at 60 and 120 minutes after glucose injection. Bar graph shows AUC of blood glucose concentration during GTT. (B) Insulin concentrations during GTT in fasted nonpregnant (n = 7) and day 14 pregnant (n = 9) rats. Bar graph shows AUC of insulin concentrations during GTT. (C) Blood glucose levels during an insulin challenge in nonpregnant (n = 7) and day 14 pregnant (n = 4) rats. Food was removed 2 hours before blood glucose was first measured. Rats were treated with insulin (IV 75 U/kg) and blood glucose levels were monitored for the next 2 hours. Bar graph shows percentage change from basal of blood glucose 15 minutes after injection. (D) Blood glucose levels during a pyruvate challenge in fasted NP and day 14 pregnant rats. Rats received either pyruvate (2 g/kg dissolved in saline; NP/nonpreg = 7; preg = 6) or vehicle (V) (nonpreg V = 3; preg V = 4) directly after blood glucose was measured at time 0, then blood glucose was monitored for 3.5 hours. Bar graph shows AUC for glucose levels during the pyruvate challenge. In all studies, nonpregnant rats were in the diestrous phase of the estrous cycle. *Significantly different from nonpregnant group, P , 0.05; **significantly different from basal/zero minute time point for same physiological state, P , 0.05. GSIS, glucose-stimulated insulin secretion; NP, nonpregnant; Preg, pregnant. doi: 10.1210/en.2017-00600 https://academic.oup.com/endoand pregnant rats had similar blood glucose levels 15 minutes after insulin treatment, the relative change from basal levels was significantly attenuated in the pregnant group (P = 0.028) because of lower initial basal blood glucose levels (Fig. 2C) . Administration of pyruvate led to increased glucose concentrations in both groups, and this increase was significant from both preinjection glucose levels [main effect of time F(1,11) = 82.95, P , 0.0001] and rats similarly injected with vehicle [main effect of treatment F(1,16) = 36.68, P , 0.0001] (Fig. 2D) . Pyruvate injection increased blood glucose to a similar degree in the pregnant and nonpregnant rats (Fig. 2D) , suggesting equivalent levels of hepatic gluconeogenesis in each group.
Endogenous hypothalamic pAkt in pregnant rats
Endogenous levels of pAkt and phospho-ERK (pERK) 1/2, both key molecules in intracellular signaling pathways activated by insulin, were measured in various hypothalamic nuclei in pregnant and nonpregnant rats approximately 45 minutes after the start of the dark phase. At this time, both groups of rats had consumed similar amounts of food, but insulin concentrations were significantly different (Fig. 1B) . Despite elevated plasma insulin concentrations in the day 14 pregnant rats, pAkt levels in the arcuate nucleus were significantly reduced compared with the nonpregnant group ( Fig. 3A ; P = 0.028), whereas pERK1/2 levels were similar. In all other areas examined, pAkt and pERK1/2 levels were similar in the nonpregnant and pregnant rats (Fig. 3B, 3C , and 3D), suggestive of reduced sensitivity to the elevated plasma insulin concentrations.
Hypothalamic response to exogenous central insulin during pregnancy
In response to an acute ICV insulin injection, there was significant attenuation of insulin-induced pAkt in the arcuate nucleus ( Fig. 4A; F(1,20) = 4.675, P = 0.043) and VMH ( Fig. 4B; F(1,19) = 7.49 P = 0.013) on day 14 of pregnancy compared with the nonpregnant group. Similar results were observed in the arcuate nucleus using immunohistochemistry for insulin-induced pAkt in pregnant and nonpregnant rats ( Fig. 5; F(1,12) = 14.85 P = 0.002). Insulin-induced pAkt in the dorsomedial nucleus (DMH) (Fig. 4C ) and paraventricular nucleus (PVN) (Fig. 4D) was similar in the nonpregnant and pregnant rats. At the time of death, blood glucose levels were not altered by prior ICV insulin injection in the nonpregnant (139.8 6 2.6 vs 137.3 6 3.7 mg/dL, P = 0.583) or pregnant rats (116.2 6 4.3 mg/dL vs 109.7 6 3.482 mg/dL, P = 0.257). As expected, however, pregnant rats had lower blood glucose levels than nonpregnant rats (two-way ANOVA, main effect of physiological state).
Insulin receptor b (IRb) and PTEN levels were similar in all areas examined in nonpregnant and pregnant rats (Fig. 6 ). Phosphorylated PTEN (pPTEN) was significantly reduced in the VMH of pregnant rats (P = 0.011), whereas no difference was observed in any other area examined (Fig. 6) . In all western blot analysis, no differences were observed in b-tubulin, b-actin, Akt, or ERK1/2 between the various treatment groups. No differences were detected in IRb, PTEN, or pPTEN between the insulin-and vehicle-treated groups of the same physiological state, so data were pooled to compare between pregnant and nonpregnant groups.
Discussion
Insulin concentrations increase during pregnancy. Our current results show increased insulin concentrations in day 14 pregnant rats compared with nonpregnant rats 45 minutes into the dark phase of the light/dark cycle following consumption of food, and increased insulin concentrations in response to exogenous glucose administration. Insulin has many functions in the brain, particularly within the hypothalamus (10, 12, 13, 16, 17, 19) , and increased insulin signaling in the hypothalamus during pregnancy, from increased insulin concentrations, may be maladaptive. Our current data demonstrate that by day 14 of pregnancy, insulin is no longer able to significantly induce pAkt in the arcuate nucleus and ventromedial nucleus. This suggests that key hypothalamic areas become insensitive to insulin during pregnancy, potentially to minimize the hypothalamic actions of the increased concentrations of insulin present at this time.
Previously, we have measured an increase in plasma insulin on day 14 of pregnancy in rats during the light phase of the 24-hour light/dark cycle (6), a time when the animals are largely inactive and not consuming food. Insulin increases after a meal (34) , so in the current study we investigated pAkt levels in the hypothalamus 45 minutes after the start of the dark phase to correspond to a time of endogenous increases in insulin concentrations and a dynamic feeding period. Following similar food consumption, pregnant rats had significantly increased insulin concentrations compared with nonpregnant rats, emphasizing the pregnancy-induced enhanced glucose-stimulated insulin secretion at this time. Increases in plasma insulin during pregnancy in the rat do vary between studies, with some groups not detecting a significant increase in basal insulin until day 18 of pregnancy (3) (4) (5) (6) (7) . Despite the increased insulin concentrations in pregnant rats, there was no increase in pAkt in any of the areas examined during pregnancy, and, in fact, significantly reduced pAkt in the arcuate nucleus compared with nonpregnant rats. Although Akt can be phosphorylated by many different factors, insulin is known to increase central levels of pAkt (31, 35) , and, given the significantly higher concentration of insulin in the pregnant group compared with the nonpregnant group, the lower endogenous arcuate nucleus pAkt at this time is highly suggestive of decreased insulin sensitivity in the arcuate nucleus during pregnancy. An alternative possibility is that there might be altered transport of insulin into the brain during pregnancy, similar to what is observed in other states of hyperinsulinemia such as models of diet-induced obesity and type 2 diabetes (36). This could account for the absence of any increase in pAkt during pregnancy in any of the areas examined. Late pregnant rats and rabbits have been shown to have lower cerebrospinal fluid insulin concentrations than virgin rats (37, 38) . These data may support the hypothesis of a reduction in insulin transport during pregnancy, but it is not clear whether insulin concentrations in cerebrospinal fluid are a good indication of its transport into the brain because insulin is thought to enter the brain by saturable transport across the blood-brain barrier and not through the choroid plexus (37, 39) . Although it is possible that decreased transport of insulin into the brain contributes to the overall reduction of the central effects of increased insulin during pregnancy, our results showing differential loss of insulin signaling in the arcuate nucleus of the Figure 3 . Phosphorylation of Akt and ERK in various hypothalamic areas from day 14 pregnant or nonpregnant female rats during the early dark phase of the light/dark cycle. Images show representative immunoblots of pAkt, Akt, pERK1 and pERK2, ERK1 and ERK2, and b-tubulin (b-tub) in hypothalamic tissue samples from nonpregnant and pregnant rats. Tissue was collected from the following hypothalamic areas: (A) arcuate nucleus, (B) VHM, (C) DMH, and (D) PVN. Phosphorylated protein levels were normalized to pan protein levels and expressed as a proportion of nonpregnant levels. Bars represent mean 6 standard error of the mean for each group. Nonpregnant rats were in the diestrous phase of the estrous cycle. *Significantly different from nonpregnant group, P , 0.05, n = 4-6 per group. NP, nonpregnant; P, pregnant. doi: 10.1210/en.2017-00600 https://academic.oup.com/endohypothalamus, whereas other insulin-responsive areas in the hypothalamus showed that normal levels of pAkt make it unlikely that the difference is simply from transport.
To specifically investigate activation of insulinresponsive cells in the hypothalamus during pregnancy, without any potential influence of decreased transport of insulin into the brain at this time, nonpregnant and pregnant rats received an ICV injection of insulin or vehicle and the levels of pAkt were measured in various different areas of the hypothalamus. In both the arcuate nucleus and the VMH, but not the DMH or PVN, there was an attenuation of insulin-induced pAkt during pregnancy. These results indicate that a region-specific insensitivity to insulin develops during pregnancy in terms of the ability of insulin to induce pAkt. We For each treatment group, phosphorylated protein levels were normalized to pan protein levels and expressed as a proportion of vehicle-treated nonpregnant levels. Bars represent mean 6 standard error of the mean for each group. Nonpregnant rats were in the diestrous phase of the estrous cycle. *Significantly different from nonpregnant group, P , 0.05, n = 5-7 per group. nonpreg, nonpregnant.
hypothesize that this attenuated signaling may protect the maternal body from the increased activation of central insulin responsive cells during pregnancy because of the elevated insulin concentrations observed at this time. Thus, the high insulin required by peripheral maternal tissues is allowed, but overstimulation of insulin responsive pathways in the brain is prevented. Insulin has been shown to be able to act centrally to decrease food intake (11) (12) (13) (14) and suppress hepatic glucose output (19) . Both of these functions would be maladaptive during pregnancy when increases in energy intake and a constant supply of glucose are required for growth and development of the fetus. Hence, attenuated signaling of insulin in the brain may represent a critical adaptation to pregnancy to suppress these functions in the face of increased insulin concentrations. Despite the presence of this adaptive response in the arcuate nucleus and VMH, insulin signaling in the DMH and PVN was sustained. It seems likely that the insulin actions in these nuclei may also be sustained or even enhanced by the elevated levels of insulin in the blood. Most of the central functions ascribed to insulin appear to be mediated within the arcuate nucleus or VMH, and functions in these other nuclei are less well defined. More work is required to determine the physiological significance of sustained signaling in these areas.
Previously, it has been shown that during late pregnancy many maternal insulin-sensitive peripheral tissues become less sensitive to insulin as glucose homeostasis undergoes pregnancy-induced modifications to maintain a steady supply of glucose to the fetus (40) .
In previous studies, glucose tolerance in a GTT has been enhanced or showed no difference from the nonpregnant state depending on the study and time point investigated (7, 25, 40) . To gain further understanding of the changes in peripheral glucose homeostasis on day 14 of pregnancy, the time at which we investigated central insulin sensitivity during pregnancy, we examined glucose tolerance and the glucose response to insulin or pyruvate administration. In our animal model, with rapid sampling procedures, we observed increased glucose tolerance on day 14 of pregnancy, alongside the increased glucosestimulated insulin concentrations, suggesting normal glucose tolerance at this time. Pregnant rats also had lower insulin-induced glucose uptake, suggestive of peripheral insulin resistance, which is thought to favor glucose usage for the fetus. Similar to our pyruvate challenge results, previous estimates of hepatic gluconeogenesis suggest that this process remains unaffected during pregnancy (25) or slightly but significantly elevated (1). However, when interpreting these results, it is challenging to compare pregnant vs nonpregnant because in the pregnant group, the results are not just a reflection of the insulin-sensitive tissues but also the noninsulin-dependent uptake of glucose by the fetus.
It has been estimated that in the basal state, the fetus can account for approximately 50% of the maternal glucose utilization rate (41) , and glucose utilization by the placenta and fetus is higher than maternal tissues in late pregnancy (2) . Glucose transfer across the placenta to the fetus is thought to be proportional to maternal blood glucose (42) . After a bolus injection of glucose into pregnant ewes, blood glucose in the fetus also increases (43) and, although the exact proportions of glucose transferred across the placenta at this time remains unknown, it is highly likely that changes in maternal blood glucose are not just a measure of glucose uptake in maternal tissues, but also glucose uptake by the placenta and transferred to the fetus. Thus, direct comparison in these experiments between nonpregnant and pregnant rats become somewhat difficult to interpret because of the presence of the glucose-using conceptus. Despite this confounding factor in interpreting the GTT results, our studies demonstrate adaptive changes that take place during pregnancy to direct glucose to the fetus and emphasize the elevated plasma insulin concentrations during pregnancy. The attenuated phosphorylation of Akt after insulin in the arcuate nucleus and VMH was not associated with any change in levels of IRb protein. To begin to elucidate the mechanisms underlying this reduced activation of Akt, we next investigated PTEN, a lipid phosphatase that negatively regulates the phosphoinositide 3-kinase/Akt pathway. PTEN dephosphorylates PIP3; the downstream effect of this is a reduction in the phosphorylation of Akt (44) . Phosphorylation of PTEN leads to a reduction in PTEN phosphatase activity (45, 46) . Inhibition of PTEN activity can decrease food intake and body weight and improve hepatic insulin sensitivity (47) . Conversely, constitutive activation of medial basal hypothalamic PTEN tends to increase food intake and body weight and reduce hepatic insulin sensitivity (47) . We hypothesized that pregnancyinduced increases in PTEN activity (i.e., dephosphorylation) may act to prevent the normal induction of pAkt by insulin. However, similar levels of PTEN were observed in the nonpregnant and pregnant rats in most of the areas investigated. A reduction in pPTEN in the VMH of pregnant rats was detected, however, suggesting that in this nucleus, there is less deactivation of PTEN during pregnancy that may contribute to reduced insulin-induced pAkt. Interestingly, the VMH has consistently shown impaired leptin sensitivity as measured by leptin-induced pSTAT3 (22, 27, 28, 48) and reduced leptin receptor messenger RNA during pregnancy (27) . Given that leptin can increase phosphorylation of PTEN (49) , the lower levels of pPTEN are consistent with the reduction of leptin signaling in the VMH during pregnancy, and it is interesting to speculate on the possibility of impaired leptin signaling driving this reduction in pPTEN in the VMH.
The results from the current study indicate that, during pregnancy, circulating insulin is elevated, but different regions of the hypothalamus show a differential response to it in terms of the ability of insulin to induce pAkt. Both the arcuate nucleus and VMH had significantly attenuated insulin-induced pAkt during pregnancy after an ICV injection of insulin, whereas both the DMH and PVN did not significantly differ from nonpregnant levels. It is likely this change in response to insulin during pregnancy in the VMH and arcuate nucleus facilitates normal adaptation to pregnancy, allowing increased food intake and enhanced, or at least not suppressed, hepatic glucose output, without compromising the increased demand of the periphery for insulin at this time. Given the increased recognition for a role of these parts of the hypothalamus in whole body glucose homeostasis, pregnancy-induced changes in these regions must be considered when evaluating the mechanisms underlying complications of glucose homeostasis during pregnancy, such as gestational diabetes mellitus. 
